Navigation Links
CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma
Date:11/3/2008

ward to further evaluating the correlation between rash and clinical activity, as well as alternate dosing schedules of CR011-vcMMAE," commented Dr. Hwu.

CuraGen is currently enrolling patients into a Phase I portion of this trial to evaluate more frequent dosing schedules of CR011-vcMMAE, including a weekly and a two out of every three-week regimen, to explore if more frequent administration can provide additional activity in patients with metastatic melanoma. CR011-vcMMAE is also being studied in an ongoing Phase II trial in patients with metastatic breast cancer who have received previous chemotherapy. CuraGen anticipates providing updated data from the ongoing melanoma and breast cancer studies in the first half of 2009.

"While we continue to finalize data from this study, develop data from more frequent dosing in patients with metastatic melanoma and from the Phase II study in patients with breast cancer, we will be engaging in discussions with potential partners as we develop plans for the advanced stages of development," added Dr. Shannon. "The goal of a partnership will be to support the financial, development and commercial resources that will be required in advanced development, improving the risk profile to CuraGen shareholders while maintaining upside potential."

In addition to M. D. Anderson, other sites participating in the melanoma trial include Yale Cancer Center, New Haven, CT; The Angeles Clinic and Research Institute, Santa Monica, CA; and New York University Medical Center, New York, NY.

Reprints of the presentation will be made available on CuraGen's website at http://www.curagen.com or can be requested by emailing info@curagen.com.

Conference Call Details and Dial-in Information

Date: Monday, November 3, 2008

Time: 11:00 a.m. EDT

Dial-in: 877-272-5391 (domestic)

706-758-4315 (international)

Passcode: 71190
'/>"/>

SOURCE CuraGen Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
2. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
3. CuraGen Announces Top-Line Phase II Results on Velafermin
4. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
5. CuraGen and TopoTarget Announce Presentation of Belinostat Clinical Trial Results at AACR-NCI-EORTC International Conference
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. CuraGen Advances CR011-vcMMAE into Phase II
8. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
10. CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer
11. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... MEETING, Pa., Nov. 20 ...hat questions why currently available medications ...ng ignored, ECRI Institute, an independent nonprof...ence on Finasteride for Prevention of Prostate Ca...2009, New York Times article, " Drugs to Deter S...
(Date:11/19/2009)...land, Nov. 19 Warner Chilcott plc ...s previously announced secondary offering of 20,00...lic of $22.25 per share. The selling shareholders...rs, DLJ Merchant Banking, J.P. Morgan Partners (ad... L.P., certain other institutional investors and m...
(Date:11/19/2009)...N, Taiwan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm...al ingredients (APIs), announced that its,Tainan f...rtification from,SafeBridge(R) Consultants, Inc. T...and proficiency in the safe handling of potent act... to specific laboratories and,production areas use...
Breaking Medicine Technology:ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 2ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Timing of Oxygen After a Stroke May Matter 59768 1Timing of Oxygen After a Stroke May Matter 59768 2PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 1PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 2PSA Nanotest May Spot Prostate Cancers Return After Surgery 59766 3Mercury Levels Not Abnormal in Autistic Children 59764 1Mercury Levels Not Abnormal in Autistic Children 59764 2Mercury Levels Not Abnormal in Autistic Children 59764 3
(Date:11/20/2009)...swire-FirstCall/ - NUCRYST Pharmaceuticals Corp. a...ers will be held on Monday, December 21, 2009. The... two special resolutions. The first special resolu...r substantially all of the assets of NUCRYST, subs...urchase agreement dated November 10, 2009 among th...
(Date:11/20/2009)...wire/ -- Following a recall by Unilever The Stop &...edd,s Country Crock ® Side Dishes DELUXE Ched... Side Dishes DELUXE Four Cheese Pasta due to an un...de dates and UPCs are affected: ,, Shedd,s Cou...oli Rice 21 oz, UPC 027400218316, Best By NOV 29 0...
(Date:11/20/2009)...SNewswire/ -- The American Dental Association (ADA...n (FDA) to establish appropriate classifications f...n about the safety of whitening products that are ...onal consultation or examination by a dentist, the...ly based tooth whitening or bleaching agents can h...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- Samuel Gladding is no Sc...means to be "happy" during the holidays. As a lice...mily counseling and chair of the Department of Cou...esearch shows that it is the pressure to be happy ...ring the holidays. ,, That,s why he,s challengi...
(Date:11/20/2009)...20 in the Journal of the National Cancer Institut...often appear in news coverage of cancer research. ... and journals to help alleviate the problem. , L...M.D., M.S., of Center for Medicine and the Media a...inical Practice in New Hampshire, and Barnett S. K...
Breaking Medicine News(10 mins):Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2
...h Nassau Communities Hospital here has appointed a...s surgery department.// Rajiv Datta is recognised ...s an internationally known leader in surgical onco... said. Datta also serves as the hospital's ...
...om many adults developing symptoms of diabetes and... of teenagers prone to cardiac problems. //A longi... beverages saturated with sugar during early stage... and type-2 diabetes has largely dealt with adults...
...sted Reproduction Unit at Quiron Hospital have suc...n a woman who is a carrier// of the disease Retino... order to avoid giving birth to a male child. This...itary illness of the eyes of a degenerative nature...
...dard treatment for new born babies who develop jau...strong light.// French researchers say that this i... skin of the babies later in life. Such moles are ... that it is important to ensure that new borns are...
...s (skin cancers) are more likely to grow rapidly i...gular borders or have symptoms//, according to a r...s more likely to occur in elderly men and individu...otal experience suggests that there is a form of r...
...study involving 44,000 American men aged 65 to 80 ...urgery// or radiation had about 30 % more chances ...ccording to the American Cancer Society estimate, ...has been that observation or 'watchful waiting' wa...
Other Medicine News:Health News:Cardiac Risk is Reduced by Cutting the Sugar in Your Drink 2Health News:Cardiac Risk is Reduced by Cutting the Sugar in Your Drink 3Health News:Characteristics of Fast-Growing Skin Cancers 2Health News:Survival Rate Better In Men Treated For Prostate Cancer Than Who Opt For ‘Wait And Watch’ Approa 2
XE-2100
Coulter LH 750 Hematology Analyzer
...he CKX microscopes utilize the infinity-corrected ...lity in cell checking. Olympus has taken this one ...esign approach with the capability of a fluorescen...th digital imaging and video monitoring. The CKX41...
CX41 Microscopes
Medicine Products: